Clinical Trial

Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 12, 2021 (before its estimated April 10, 2022 completion). Its status may not reflect the trial's current state.
Summary
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-04-05; most recent amendment 2024-03-26.
Status change: Recruiting → Completed 2024-03-26
Trial Details
NCT Number NCT03906617
Lead Sponsor The Cooper Health System
Conditions Robotic Lung Surgery
Enrollment 34 participants
Start Date 2019-04-10
Primary Completion 2022-04-10 (estimated)
Study Completion 2022-06-10 (estimated)
Updated on ClinicalTrials.gov 2021-11-12